Hortencia Guzman
Medical · San Diego, CANPI 1982785739
Payments from drug & device makers
Across 77 payments — averaging $30.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$425
- Lilly USA, LLC$268
- Biotronik Inc.$229
- Medtronic$215
- Shockwave Medical, Inc$158
- Bayer$153
- plus $916 from 16 others
What the payments were for
- Travel & lodging$90%
- Food & beverage$2,354100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $425 |
| Lilly USA, LLC | 8 | $268 |
| Biotronik Inc. | 7 | $229 |
| Medtronic | 5 | $215 |
| Shockwave Medical, Inc | 1 | $158 |
| Bayer | 5 | $153 |
| Dexcom, Inc. | 6 | $130 |
| Xeris Pharmaceuticals, Inc. | 3 | $124 |
| Edwards Lifesciences | 1 | $116 |
| AstraZeneca | 6 | $98 |
| AbbVie | 5 | $88 |
| Astellas Pharma US Inc | 3 | $78 |
| GSK | 3 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Pfizer | 2 | $32 |
| Boehringer Ingelheim | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Smith+Nephew | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,363 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $80,993 |
| TrulicityDulaglutide | 56 | $60,613 |
| JanuviaSitagliptin Phosphate | 49 | $56,373 |
| JardianceEmpagliflozin | 49 | $49,286 |
| RybelsusSemaglutide | 44 | $48,441 |
| EliquisApixaban | 45 | $34,657 |
| TradjentaLinagliptin | 55 | $34,435 |
| Diclofenac Sodium | 140 | $20,411 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $12,386 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $11,599 |
| FarxigaDapagliflozin Propanediol | 13 | $8,824 |
| Qvar RedihalerBeclomethasone Dipropionate | 25 | $8,094 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $5,905 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $5,732 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 15 | $5,492 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $425 | $129,434115 claims |
| Boehringer IngelheimJardiance, Tradjenta | $25 | $83,721104 claims |
| Lilly USA, LLCTrulicity | $268 | $60,61356 claims |
| PfizerEliquis | $32 | $34,65745 claims |
| AstraZenecaFarxiga | $98 | $8,82413 claims |
| AbbVieSynthroid | $88 | $3,62055 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 medical providers in California.
Other medical in San Diego
- Cheryl KyinnSan Diego$103K
- Touraj YariSan Diego$27K
- Aaron WillcottSan Diego$23K
- Yuchao JinSan Diego$22K
- Carter CopelandSan Diego$17K
- Cameron ChanSan Diego$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.